Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: AgAuUSA who wrote (9581)	7/1/1998 1:23:00 PM
From: dowman	Read Replies (2) \| Respond to of 14328

Not short, and there is no short position in this stock to speak of.I have already said I owned in the past and have no position currently. Came back to see if there was any more information, but it seems there is nothing but the same lack of real information from the company. HIV2 is a perfect example. Check out the facts about HIV2 with any company in the aids testing business and you will discover the truth of my post. If the FDA changes their position, this may recede. If not, this will be a problem for ANY company without a license. And with Abbott holding a license, and developing their next generation test, the future may look different than you perceive.

To: AgAuUSA who wrote (9581)	7/1/1998 1:34:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 14328

The delema 4 a lot of investors is that right now, there are a LOT of "steals" in the small cap/tech area. Question is where to have money for the next 6 months. If a company is attractively valued and has great prospects, but stands to get hamered during tax selling season, why buy now? This does not just apply to TRIBY. EQNX, SEEQ, BARR, INVX, PTIX spring immediatly to mind. They might be even more attractively valued in late Dec. FYI Scott